PL1629850T3 - Kompozycja odżywcza zawierająca niestrawne transgalaktooligosacharydy i strawne galaktozosacharydy - Google Patents

Kompozycja odżywcza zawierająca niestrawne transgalaktooligosacharydy i strawne galaktozosacharydy

Info

Publication number: PL1629850T3
Authority: PL; Poland
Prior art keywords: transgalactooligosaccharides; indigestible; nutritional composition; digestible galactose; composition
Prior art date: 2004-08-24

Application number

PL04077394T

Other languages

English (en)

Other versions

PL1629850T5 (pl

Inventor

Günther Boehm

Laura M'rabet

Bernd Stahl

Johan Garssen

Original Assignee

Nutricia Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-24

Filing date

2004-08-24

Publication date

2007-09-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34928473&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1629850(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-08-24 Application filed by Nutricia Nv filed Critical Nutricia Nv

2007-09-28 Publication of PL1629850T3 publication Critical patent/PL1629850T3/pl

2013-09-30 Publication of PL1629850T5 publication Critical patent/PL1629850T5/pl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/519—Breve

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Mycology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Nutrition Science (AREA)
Microbiology (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Diabetes (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pediatric Medicine (AREA)
Oil, Petroleum & Natural Gas (AREA)
Immunology (AREA)
Hematology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL04077394T 2004-08-24 2004-08-24 Kompozycja odżywcza zawierająca niestrawne transgalaktooligosacharydy i strawne galaktozosacharydy PL1629850T5 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP04077394.7A EP1629850B2 (en)	2004-08-24	2004-08-24	Nutritional composition comprising indigestible transgalactooligosaccharides and digestible galactose saccharides

Publications (2)

Publication Number	Publication Date
PL1629850T3 true PL1629850T3 (pl)	2007-09-28
PL1629850T5 PL1629850T5 (pl)	2013-09-30

Family

ID=34928473

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL04077394T PL1629850T5 (pl)	2004-08-24	2004-08-24	Kompozycja odżywcza zawierająca niestrawne transgalaktooligosacharydy i strawne galaktozosacharydy
PL10180272.6T PL2359858T3 (pl)	2004-08-24	2005-08-24	Kompozycja odżywcza zawierająca nieulegające trawieniu oligosacharydy

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL10180272.6T PL2359858T3 (pl)	2004-08-24	2005-08-24	Kompozycja odżywcza zawierająca nieulegające trawieniu oligosacharydy

Country Status (19)

Country	Link
US (4)	US8277835B2 (pl)
EP (5)	EP1629850B2 (pl)
JP (1)	JP5142717B2 (pl)
CN (2)	CN101043904B (pl)
AT (1)	ATE361101T1 (pl)
AU (2)	AU2005275577B2 (pl)
BR (1)	BRPI0514536A (pl)
CA (2)	CA2577926C (pl)
DE (1)	DE602004006258T3 (pl)
DK (2)	DK1629850T4 (pl)
ES (3)	ES2286558T5 (pl)
NZ (1)	NZ553390A (pl)
PL (2)	PL1629850T5 (pl)
PT (2)	PT1629850E (pl)
RU (2)	RU2385725C2 (pl)
SG (1)	SG170119A1 (pl)
TR (1)	TR201820868T4 (pl)
UA (1)	UA89791C2 (pl)
WO (2)	WO2006022542A1 (pl)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080126195A1 (en)	2004-07-22	2008-05-29	Ritter Andrew J	Methods and Compositions for Treating Lactose Intolerance
PT1629850E (pt)	2004-08-24	2007-08-14	Nutricia Nv	Composição nutricional que compreende a administração de oligossacarídeos indigeríveis
US20060229366A1 (en) *	2005-04-07	2006-10-12	Lifschitz Carlos H	Method for preventing or treating respiratory infections in infants
EP1714660A1 (en) *	2005-04-21	2006-10-25	N.V. Nutricia	Uronic acid and probiotics
EP1776877A1 (en) *	2005-10-21	2007-04-25	N.V. Nutricia	Method for stimulating the intestinal flora
US20070202215A1 (en) *	2006-02-28	2007-08-30	Zahramehran Salari Lak	Dietary nutritional supplements for persons consuming alcohol products
PL1993576T3 (pl) *	2006-03-07	2016-04-29	Nestec Sa	Mieszanina synbiotyczna
WO2008054193A1 (en)	2006-11-02	2008-05-08	N.V. Nutricia	Nutritional products that comprise saccharide oligomers
NL1032840C2 (nl) *	2006-11-09	2008-05-13	Friesland Brands Bv	Probiotische hydrolysaatvoeding voor kinderen.
WO2008153377A1 (en) *	2007-06-15	2008-12-18	N.V. Nutricia	Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
US20110008258A1 (en) *	2007-11-12	2011-01-13	Samsara Medicin Ab	Methods relating to breathing disorders
US20110223248A1 (en) *	2007-12-12	2011-09-15	Ritter Pharmaceuticals, Inc.	Methods and compositions for treating lactose intolerance
PT2265135T (pt) *	2008-03-14	2018-02-21	Nestec Sa	Mistura simbiótica
EP2130440A1 (en) *	2008-06-06	2009-12-09	N.V. Nutricia	Inhibiting E. sakazakii growth
WO2009157759A1 (en) *	2008-06-23	2009-12-30	N.V. Nutricia	Nutritional composition for improving the mammalian immune system
WO2010002241A1 (en) *	2008-06-30	2010-01-07	N.V. Nutricia	Nutritional composition for infants delivered via caesarean section
US20100043075A1 (en) *	2008-08-13	2010-02-18	Autodesk, Inc.	Licensing management utility
WO2010068086A1 (en) *	2008-12-11	2010-06-17	N.V. Nutricia	Nutritional compositions with large lipid globule size
US8785160B2 (en)	2009-02-24	2014-07-22	Ritter Pharmaceuticals, Inc.	Prebiotic formulations and methods of use
SG10201901259RA (en)	2009-02-24	2019-03-28	Ritter Pharmaceuticals Inc	Prebiotic formulations and methods of use
JP5860396B2 (ja) *	2009-05-11	2016-02-16	ネステクソシエテアノニム	ラクトバチルス・ジョンソニーＬａ１ＮＣＣ５３３（ＣＮＣＭＩ−１２２５）及び免疫障害
WO2011008086A1 (en)	2009-07-15	2011-01-20	N.V. Nutricia	Mixture of non-digestible oligosaccharides for stimulating the immune system
PL2453901T3 (pl) *	2009-07-15	2015-03-31	Nutricia Nv	Fukozyloklaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania infekcji wirusowych
EP2322169A1 (en) *	2009-11-13	2011-05-18	Laboratorios Casen-Fleet, S.L.	Composition containing a DHA oil for use in the treatment of cystic fibrosis
NL2004099C2 (en) *	2010-01-15	2011-07-18	Friesland Brands Bv	Milk derived antigen specific antibodies for inducing an adaptive immune response, methods of preparation and uses thereof.
BE1019290A5 (nl)	2010-04-14	2012-05-08	Nutrition Sciences Nv Sa	Voedingsupplement omvattende oligosachariden en middellange keten vetzuren.
ES2742734T3 (es)	2010-11-23	2020-02-17	Pantheryx Inc	Composiciones y procedimientos para el tratamiento en aplicaciones clínicas de espectro general, no diferenciadas o mixtas
EP2465509A1 (en)	2010-11-23	2012-06-20	Nestec S.A.	Oligosaccharide composition for treating acute respiratory tract infections
WO2012087113A1 (en)	2010-12-24	2012-06-28	N.V. Nutricia	Improved nutritional tablet
US8802650B2 (en)	2010-12-31	2014-08-12	Abbott Laboratories	Methods of using human milk oligosaccharides for improving airway respiratory health
CA2822490C (en)	2010-12-31	2020-03-31	Abbott Laboratories	Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
MY166945A (en)	2010-12-31	2018-07-25	Abbott Lab	Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
ES2667393T3 (es) *	2010-12-31	2018-05-10	Abbott Laboratories	Oligosacáridos de leche humana para modular inflamación
JP5900792B2 (ja) *	2011-02-21	2016-04-06	国立大学法人信州大学	フェルラ酸結合型糖質の製造方法
US8563611B2 (en) *	2011-03-17	2013-10-22	Women's & Children's Health Research Institute	Methods and compositions for promoting the respiratory development of an infant
RU2464796C1 (ru) *	2011-06-01	2012-10-27	Государственное образовательное учреждение высшего профессионального образования Воронежская государственная технологическая академия (ГОУ ВПО ВГТА)	Способ получения фукозосодержащей функциональной добавки из молочной сыворотки
CA2839524C (en)	2011-06-20	2016-05-17	H.J. Heinz Company	Probiotic compositions and methods
WO2012177118A1 (en)	2011-06-22	2012-12-27	N.V. Nutricia	Method for reducing the occurrence of infection in young children
GB201112091D0 (en)	2011-07-14	2011-08-31	Gt Biolog Ltd	Bacterial strains isolated from pigs
NL2007268C2 (en)	2011-08-16	2013-02-19	Friesland Brands Bv	Nutritional compositions comprising human milk oligosaccharides and uses thereof.
GB201117313D0 (en)	2011-10-07	2011-11-16	Gt Biolog Ltd	Bacterium for use in medicine
RU2471496C1 (ru) *	2011-11-17	2013-01-10	Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии Сибирского отделения РАМН	Средства, повышающие противоопухолевую и антиметастатическую активность цитостатических препаратов
BR112015014420A2 (pt)	2012-12-18	2017-07-11	Abbott Lab	oligossacarídeos do leite humano para melhorar sintomas de estresse
ITMI20122270A1 (it)	2012-12-31	2014-07-01	Giovanni Mogna	Terapia di supporto ai trattamenti di chemioterapia per i tumori, per la sindrome da immunodeficienza acquisita e per le leucemie.
GB201306536D0 (en)	2013-04-10	2013-05-22	Gt Biolog Ltd	Polypeptide and immune modulation
ES2729641T3 (es)	2013-05-10	2019-11-05	Heinz Co Brands H J Llc	Probióticos y métodos de uso
SE537951C2 (sv) *	2013-07-01	2015-12-01	Hero Ag	Profylaktisk användning av modersmjölksersättning mot otit
CN105722515A (zh)	2013-11-15	2016-06-29	雀巢产品技术援助有限公司	用于预防或治疗有风险婴儿或幼儿的urt感染的组合物
JPWO2016042831A1 (ja) *	2014-09-18	2017-04-27	協和化学工業株式会社	大腸の検査または手術のための処置用製剤
KR20170091157A (ko)	2014-12-23	2017-08-08	4디 파마 리서치 리미티드	피린 폴리펩티드 및 면역 조정
PL3065748T3 (pl)	2014-12-23	2018-07-31	4D Pharma Research Limited	Szczep Bacteroides thetaiotaomicron i jego zastosowanie w zmniejszaniu zapalenia
EA201890050A1 (ru)	2015-06-15	2018-06-29	4Д Фарма Рисёрч Лимитед	Композиции, содержащие бактериальные штаммы
MA41010B1 (fr)	2015-06-15	2020-01-31	4D Pharma Res Ltd	Compositions comprenant des souches bactériennes
SI3240554T1 (sl)	2015-06-15	2019-12-31	4D Pharma Research Limited,	Blautia stercosis in wexlerae za uporabo v zdravljenju vnetnih in avtoimunskih bolezni
MA41060B1 (fr)	2015-06-15	2019-11-29	4D Pharma Res Ltd	Compositions comprenant des souches bactériennes
MD3650033T2 (ro)	2015-06-15	2022-08-31	4D Pharma Res Ltd	Compoziții conţinând tulpini bacteriene
WO2017021413A1 (en) *	2015-08-04	2017-02-09	Südzucker AG	Prophylactic use of inulin against sinusitis
AU2016357554B2 (en)	2015-11-20	2019-04-04	Cj Bioscience, Inc.	Compositions comprising bacterial strains
GB201520497D0 (en)	2015-11-20	2016-01-06	4D Pharma Res Ltd	Compositions comprising bacterial strains
GB201520638D0 (en)	2015-11-23	2016-01-06	4D Pharma Res Ltd	Compositions comprising bacterial strains
GB201520631D0 (en)	2015-11-23	2016-01-06	4D Pharma Res Ltd	Compositions comprising bacterial strains
EP3389404B1 (en)	2015-12-15	2019-10-02	Société des Produits Nestlé S.A.	Mixture of hmos
WO2017114901A1 (en) *	2015-12-29	2017-07-06	N.V. Nutricia	Nutritional formula with non-digestible oligosaccharides and non-replicating lactic acid producing bacteria
EP3207933A1 (en) *	2016-02-17	2017-08-23	Proponent Biotech GmbH	Uses of polyfructans
EP3520801A1 (en)	2016-03-04	2019-08-07	4D Pharma Plc	Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
GB201612191D0 (en)	2016-07-13	2016-08-24	4D Pharma Plc	Compositions comprising bacterial strains
TW201821093A (zh)	2016-07-13	2018-06-16	英商４Ｄ製藥有限公司	包含細菌菌株之組合物
GB201621123D0 (en)	2016-12-12	2017-01-25	4D Pharma Plc	Compositions comprising bacterial strains
JP7212945B2 (ja)	2017-05-22	2023-01-26	フォーディーファーマリサーチリミテッド	細菌株を含む組成物
TW201907931A (zh)	2017-05-24	2019-03-01	英商4D製藥研究有限公司	包含細菌菌株之組合物
CN115813955A (zh)	2017-06-14	2023-03-21	4D制药研究有限公司	包含细菌菌株的组合物
MD3804737T2 (ro)	2017-06-14	2022-10-31	4D Pharma Res Limited	Compoziții care conțin tulpini bacteriene
WO2018229188A1 (en)	2017-06-14	2018-12-20	4D Pharma Research Limited	Compositions comprising bacterial strains
WO2019031961A1 (en)	2017-08-11	2019-02-14	N.V. Nutricia	OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
EP3479699A1 (en) *	2017-11-03	2019-05-08	Agriculture and Food Development Authority (TEAGASC)	A composition and uses thereof
US20210161924A1 (en) *	2018-06-19	2021-06-03	Evolve Biosystems, Inc.	Novel oligosaccharides for use in prebiotic applications
CN108888762A (zh) *	2018-08-15	2018-11-27	福建傲农生物科技集团股份有限公司	一种含益生菌代谢产物的组合物
WO2020176637A1 (en)	2019-02-26	2020-09-03	Pantheryx, Inc.	Compositions for management of disorders of the gastrointestinal tract
WO2021013862A1 (en) *	2019-07-23	2021-01-28	Frieslandcampina Nederland B.V.	Nutritional composition comprising milk fat and immunoglobulin
JP2023520558A (ja) *	2020-04-06	2023-05-17	アボット・ラボラトリーズ	呼吸器系誘導性サイトカインを調節する栄養処方剤
WO2021222660A1 (en) *	2020-04-30	2021-11-04	Kaleido Biosciences, Inc.	Oligosaccharide compositions and methods of use thereof for treating viral infections
US11331329B2 (en) *	2020-05-13	2022-05-17	Glycosyn LLC	Fucosylated oligosaccharides for prevention of coronavirus infection
US11324766B2 (en)	2020-05-13	2022-05-10	Glycosyn LLC	2'-fucosyllactose for the prevention and treatment of coronavirus-induced inflammation
US20240366654A1 (en) *	2021-07-16	2024-11-07	Purdue Research Foundation	Prebiotic composition and method of use to improve gastrointestinal health in patients with dysbiosis and leaky gut
CN117481270A (zh) *	2023-10-12	2024-02-02	希德罗(合肥)宠物用品有限公司	一种宠物用补血片剂及其制备方法

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH627079A5 (en)	1977-04-15	1981-12-31	Nestle Sa	Process for preparing a protein concentrate containing immunological factors of milk origin
SE8301609D0 (sv)	1983-03-23	1983-03-23	Svenska Sockerfabriks Ab	Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
US4661345A (en)	1985-02-26	1987-04-28	The Rockefeller University	Method for treating pertussis
NZ222902A (en)	1986-12-15	1990-08-28	Yakult Honsha Kk	Method for producing galactooligosaccharide
US4800078A (en) *	1987-05-28	1989-01-24	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
SE462134B (sv)	1987-10-22	1990-05-14	Biocarb Ab	Livsmedel innehaallande lacto-n-tetraos och foerfarande foer dess framstaellning
CA2095642C (en)	1990-08-02	1999-12-14	Howard C. Krivan	Adhesion receptors for pathogenic or opportunistic microorganisms
US5902617A (en) *	1992-05-19	1999-05-11	Pabst; Patrea L.	Enzyme supplemented baby formula
US5531989A (en)	1994-10-28	1996-07-02	Metagenics, Inc.	Immunoglobulin and fiber-containing composition for human gastrointestinal health
US5922344A (en)	1995-02-10	1999-07-13	Abbott Laboratories	Product for prevention of respiratory virus infection and method of use
US5736533A (en)	1995-06-07	1998-04-07	Neose Technologies, Inc.	Bacterial inhibition with an oligosaccharide compound
EP1254664A3 (en)	1995-07-10	2004-01-02	Abbott Laboratories	Enteral products containing indigestible oligosaccharides for treating and preventing otitis media in humans
EP0756828B2 (en)	1995-08-04	2010-09-22	N.V. Nutricia	Nutritional composition containing fibres
CA2245497C (en) *	1996-03-01	2009-02-24	Novartis Ag	Peptide immunogens for vaccination against and treatment of allergy
AU745551B2 (en)	1997-03-27	2002-03-21	Bristol-Myers Squibb Company	Use of docosahexanoic acid and arachidonic acid enhancing the growth of preterm infants
US5906982A (en)	1997-03-31	1999-05-25	Abbott Laboratories	Nutritional formulations containing Lacto-N-neoTetraose
US6045854A (en)	1997-03-31	2000-04-04	Abbott Laboraties	Nutritional formulations containing oligosaccharides
US6145670A (en) *	1997-09-22	2000-11-14	Risser; William	Bathtub spout with removable filter
DE19836339B4 (de)	1998-08-11	2011-12-22	N.V. Nutricia	Kohlenhydratmischung
DK0951842T3 (da)	1999-01-20	2003-01-06	Nutricia Nv	Ernæringsprodukt til et spædbarn
RU2141842C1 (ru) *	1999-05-05	1999-11-27	Бухтиярова Марина Георгиевна	Способ пренатальной профилактики респираторного дистресс-синдрома у недоношенных новорожденных
RU2149633C1 (ru) *	1999-09-01	2000-05-27	Хачатрян Ашот Папикович	Способ лечения иммунодефицитных состояний организма
EP1062873A1 (en) *	1999-12-13	2000-12-27	N.V. Nutricia	Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
DE10006989A1 (de)	2000-02-16	2001-08-23	Nutricia Nv	Antiadhäsive Kohlenhydratmischung
FR2809312B1 (fr) *	2000-05-25	2002-07-12	Gervais Danone Sa	Utilisation de l. casei dans des compositions immunostimulantes
WO2001093683A1 (en) *	2000-06-07	2001-12-13	Watson Pharmaceuticals, Inc.	Treating smooth muscle hyperactivity with (r)-oxybutynin and (r)- desethyloxybutynin
WO2001097817A1 (en)	2000-06-21	2001-12-27	James Zhou Liu	Health promoting foods
GB0016045D0 (en)	2000-06-29	2000-08-23	Laxdale Limited	Therapeutic combinations of fatty acids
DE10057976B4 (de)	2000-11-22	2005-02-03	Südzucker AG Mannheim/Ochsenfurt	Verfahren zur Herstellung von Pektinhydrolyseprodukten
EP1355542B2 (en) *	2000-12-27	2012-04-04	N.V. Nutricia	Nutritional composition with health promoting action containing oligosaccharides
FI109602B (fi) *	2001-01-25	2002-09-13	Valio Oy	Probioottiyhdistelmä
DE10147100A1 (de) *	2001-09-25	2003-04-17	Numico Res B V	Antiinfektive Kohlenhydrate
AU2002325026A1 (en)	2001-09-27	2003-04-07	St. Jude Children's Research Hospital, Inc.	Use of neuraminidase inhibitors to prevent flu associated bacterial infections
US6946451B2 (en)	2002-02-04	2005-09-20	Kyowa Hakko Kogyo Co., Ltd.	Insulin secretion promoter
DK1531832T3 (da)	2002-06-28	2009-07-27	Glykos Finland Oy	Terapeutiske sammensætninger til anvendelse ved profylakse eller behandling af diarré
GB0229015D0 (en) *	2002-12-12	2003-01-15	Novartis Nutrition Ag	New Compound
US7862808B2 (en)	2004-07-01	2011-01-04	Mead Johnson Nutrition Company	Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
EP1634599A1 (en)	2004-08-20	2006-03-15	N.V. Nutricia	Iimmune stimulatory infant nutrition
PT1629850E (pt)	2004-08-24	2007-08-14	Nutricia Nv	Composição nutricional que compreende a administração de oligossacarídeos indigeríveis
US8802650B2 (en)	2010-12-31	2014-08-12	Abbott Laboratories	Methods of using human milk oligosaccharides for improving airway respiratory health

2004
- 2004-08-24 PT PT04077394T patent/PT1629850E/pt unknown
- 2004-08-24 DE DE602004006258T patent/DE602004006258T3/de not_active Expired - Lifetime
- 2004-08-24 ES ES04077394T patent/ES2286558T5/es not_active Expired - Lifetime
- 2004-08-24 AT AT04077394T patent/ATE361101T1/de active
- 2004-08-24 PL PL04077394T patent/PL1629850T5/pl unknown
- 2004-08-24 EP EP04077394.7A patent/EP1629850B2/en not_active Expired - Lifetime
- 2004-08-24 DK DK04077394.7T patent/DK1629850T4/da active
2005
- 2005-08-24 CA CA2577926A patent/CA2577926C/en not_active Expired - Fee Related
- 2005-08-24 SG SG201101844-7A patent/SG170119A1/en unknown
- 2005-08-24 US US11/574,123 patent/US8277835B2/en not_active Expired - Lifetime
- 2005-08-24 UA UAA200701942A patent/UA89791C2/ru unknown
- 2005-08-24 PL PL10180272.6T patent/PL2359858T3/pl unknown
- 2005-08-24 EP EP05775176A patent/EP1784218A1/en not_active Ceased
- 2005-08-24 WO PCT/NL2005/000611 patent/WO2006022542A1/en not_active Ceased
- 2005-08-24 NZ NZ553390A patent/NZ553390A/xx not_active IP Right Cessation
- 2005-08-24 DK DK10180272.6T patent/DK2359858T3/da active
- 2005-08-24 BR BRPI0514536-8A patent/BRPI0514536A/pt not_active Application Discontinuation
- 2005-08-24 AU AU2005275577A patent/AU2005275577B2/en not_active Ceased
- 2005-08-24 EP EP14173107.5A patent/EP2851090A1/en not_active Withdrawn
- 2005-08-24 EP EP10180272.6A patent/EP2359858B1/en not_active Revoked
- 2005-08-24 ES ES05775158T patent/ES2704599T3/es not_active Expired - Lifetime
- 2005-08-24 PT PT101802726T patent/PT2359858T/pt unknown
- 2005-08-24 JP JP2007529745A patent/JP5142717B2/ja not_active Expired - Lifetime
- 2005-08-24 ES ES10180272T patent/ES2929515T3/es not_active Expired - Lifetime
- 2005-08-24 EP EP05775158.8A patent/EP1784222B1/en not_active Revoked
- 2005-08-24 TR TR2018/20868T patent/TR201820868T4/tr unknown
- 2005-08-24 RU RU2007110822/15A patent/RU2385725C2/ru active
- 2005-08-24 CN CN2005800358190A patent/CN101043904B/zh not_active Expired - Lifetime
- 2005-08-24 CA CA2576562A patent/CA2576562C/en not_active Expired - Lifetime
- 2005-08-24 AU AU2005275576A patent/AU2005275576B2/en not_active Expired
- 2005-08-24 US US11/574,180 patent/US9566291B2/en active Active
- 2005-08-24 WO PCT/NL2005/000612 patent/WO2006022543A1/en not_active Ceased
- 2005-08-24 RU RU2007110813/15A patent/RU2385714C2/ru not_active IP Right Cessation
- 2005-08-24 CN CN2005800355239A patent/CN101094687B/zh not_active Expired - Fee Related
2012
- 2012-09-14 US US13/620,216 patent/US20130102560A1/en not_active Abandoned
2014
- 2014-03-05 US US14/198,421 patent/US20140296179A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ATE361101T1 (de)	2007-05-15
EP2851090A1 (en)	2015-03-25
CN101094687A (zh)	2007-12-26
PL1629850T5 (pl)	2013-09-30
ES2929515T3 (es)	2022-11-29
DK2359858T3 (da)	2022-10-31
EP1784218A1 (en)	2007-05-16
AU2005275577A1 (en)	2006-03-02
US20070274983A1 (en)	2007-11-29
EP1629850A1 (en)	2006-03-01
RU2007110822A (ru)	2008-10-10
PT1629850E (pt)	2007-08-14
DE602004006258T2 (de)	2008-01-10
CN101043904A (zh)	2007-09-26
JP2008510803A (ja)	2008-04-10
BRPI0514536A (pt)	2008-06-17
US20140296179A1 (en)	2014-10-02
AU2005275577B2 (en)	2011-03-10
ES2286558T5 (es)	2013-10-15
EP1629850B1 (en)	2007-05-02
EP1784222B1 (en)	2018-10-10
AU2005275576B2 (en)	2011-07-07
JP5142717B2 (ja)	2013-02-13
US8277835B2 (en)	2012-10-02
CA2577926A1 (en)	2006-03-02
AU2005275576A1 (en)	2006-03-02
DE602004006258T3 (de)	2013-08-29
PT2359858T (pt)	2022-11-09
WO2006022542A1 (en)	2006-03-02
US20130102560A1 (en)	2013-04-25
NZ553390A (en)	2009-11-27
DK1629850T4 (da)	2013-07-01
CA2577926C (en)	2016-08-16
EP2359858A1 (en)	2011-08-24
US20080124323A1 (en)	2008-05-29
AU2005275576A2 (en)	2006-03-02
RU2385725C2 (ru)	2010-04-10
CN101094687B (zh)	2011-07-27
EP1784222A1 (en)	2007-05-16
DE602004006258D1 (de)	2007-06-14
EP2359858B1 (en)	2022-08-10
UA89791C2 (ru)	2010-03-10
CA2576562C (en)	2016-03-01
CN101043904B (zh)	2012-04-18
US9566291B2 (en)	2017-02-14
EP1629850B2 (en)	2013-05-22
ES2704599T3 (es)	2019-03-19
TR201820868T4 (tr)	2019-01-21
WO2006022543A1 (en)	2006-03-02
RU2007110813A (ru)	2008-10-10
DK1629850T3 (da)	2007-09-10
CA2576562A1 (en)	2006-03-02
SG170119A1 (en)	2011-04-29
ES2286558T3 (es)	2007-12-01
PL2359858T3 (pl)	2022-12-19
RU2385714C2 (ru)	2010-04-10

Publication	Publication Date	Title
PL1629850T5 (pl)	2013-09-30	Kompozycja odżywcza zawierająca niestrawne transgalaktooligosacharydy i strawne galaktozosacharydy
PL1721612T3 (pl)	2009-09-30	Immunomodulujące oligosacharydy
WO2008076915A8 (en)	2009-06-11	Treatment of pigs with pcv2 antigen
WO2007115282A3 (en)	2007-12-21	Use of ketogenic compounds for treatment of age-associated memory impairment
WO2002007533A3 (en)	2002-04-11	Nutritional composition
NO20032129L (no)	2003-07-11	N¶ringssammensetning for en immuntilstand
WO2004112509A3 (en)	2006-08-03	Nutritional formula for optimal gut barrier function
EP2248527A3 (en)	2013-04-03	Compositions and methods for the control, prevention, and treatment of obesity and eating disorders
WO2008043424A3 (en)	2008-06-19	Composition to treat or prevent gastrointestinal infection
WO2004034930A3 (de)	2004-08-05	Implantat in der harnblase
EG25067A (en)	2011-07-26	Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals.
WO2004066862A3 (en)	2005-08-04	Method and composition for improving the health of young monogastric mammals
EP1670490A4 (en)	2009-08-12	PROCESS FOR INHIBITING BACTERIAL COLLISION
WO2005056601A3 (en)	2006-05-18	Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse?
ATE458004T1 (de)	2010-03-15	Osteoprotegerin in milch
US20220079891A1 (en)	2022-03-17	Combination therapy of phosphate binders and vitamin k
TH83718A (th)	2007-03-29	วิธีการและองค์ประกอบสำหรับยับยั้งการติดเชื้อจาก Helicobacter Pylori โดยการรับโปรไซยานิดินชนิด B และ C
TH83718B (th)	2007-03-29	" วิธีการและองค์ประกอบสำหรับยับยั้งการติดเชื้อจาก Helicobacter Pylori โดยการรับโปรไซยานิดินชนิด B และ C "